chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Admitted 10/7/2021.  Currently in COVID ICU.    pt arrives via ems brought from dialysis-while she was at dialysis she recieved a call that her roommate. patient is covid +. patient has weakness, cough, fever, dyspnea. History of Present Illness  she is a 56yo female with h/o ESRD on HD TTS, CAD s/p CABG, HTN, HLD, DM2, asthma, OSA on 2L QHS and PRN, obesity, anemia, paroxysmal AFib that p/w COVID.  Patient has been at a facility where several other patients have been positive.  She noted yesterday she had fatigue, cough with SOB (she has chronic cough clear sputum).  She did note a subjective fever yesterday.  This am she felt okay, went to HD and about 3 hours in was notified her room
Pt recvd a series of 3 Engerix-B doses 07NOV90, 05DEC90, & 13MAY91 & it was determined 12JUN91 that pt was not protected; no tx given as of 17JUN91;
Approximately 2 hours after getting vaccines the patient's father called saying he could not breathe easily and was having trouble swallowing.  Instructed to go to the er ASAP.
30 minutes after receiving the vaccine he developed musculoskeletal chest pain, 2 hours later weakness in the left arm (opposite arm of immunization).  Arm weakness has resolved.  Musculoskeletal chest pain continues as of today 9/16/15.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Mild, Systemic: Seizure-Severe, Systemic: Shakiness-Severe, Systemic: Weakness-Severe, Additional Details: After confirming that the patient did not have allergies or any previous adverse reactions to any vaccines in general, immediately after the vaccine, the patient's eyes had rolled to the back of their head and he began to go limp. His body shook for a few seconds. He quickly regained consciousness but was very weak and confused. His sister stated that he has a fear of needles. He felt nauseous (did not vomit) and felt like his heart was racing but his pulse was normal.
Within hours of receiving the vacination my pain levels from the pre-existing injuries increased from a level of 1/10 to 8/10. The pain became more managable after 24 hours and returned to normal levels within 48 hours.
FELT HAD NOT SLEPT MUCH; INJECTION SITE TENDER TO TOUCH; 1 INCH LUMP AT INJECTION SITE; PAIN AT INJECTION SITE; TIREDNESS/FATIGUE; This spontaneous report received from a patient concerned a 65 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, and bladder issues. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included paroxetine for hypertension.  On 06-APR-2021, the subject experienced 1 inch lump at injection site. On 06-APR-2021, the subject experienced pain at injection site. On 06-APR-2021, the subject experienced tiredness/fatigue. On an unspecified date, the subject experienced felt had not slept much, and injection site tender to touch. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from pain at injection site, and tiredness/fatigue, had not recovered from 1 inch lump at injection site, and injection site tender to touch, and the outcome of felt had not slept much was not reported. This report was non-serious.
Itching, warm to touch, and redness at injection site.  I have not contacted my family Dr. will call on Monday
Large (baseball sized) red rash about two inches below the injection spot. Painful, swollen, inflamed.  Chills, shakes, extreme body aches, extreme lethargy, flu like symptoms for one-two days. Low temp 97.1-7.
Can't raise my right arm; I have no strength in my right arm at all; I had flu-like symptoms; Was hot; I think I had a fever; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can't raise my right arm), INJECTION SITE MUSCLE WEAKNESS (I have no strength in my right arm at all), INFLUENZA LIKE ILLNESS (I had flu-like symptoms), FEELING HOT (Was hot) and PYREXIA (I think I had a fever) in a 74-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7144B) for COVID-19 prophylaxis.     No medical history reported.  It was unknown if the patient ever had COVID positive test or diagnosis.  Concomitant products included INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Sep-2022, the patient experienced INFLUENZA LIKE ILLNESS (I had flu-like symptoms), FEELING HOT (Was hot) and PYREXIA (I think I had a fever). On 14-Sep-2022, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can't raise my right arm) and INJECTION SITE MUSCLE WEAKNESS (I have no strength in my right arm at all). The patient was treated with PARACETAMOL (TYLENOL) on 10-Sep-2022 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can't raise my right arm) and INJECTION SITE MUSCLE WEAKNESS (I have no strength in my right arm at all) had not resolved and INFLUENZA LIKE ILLNESS (I had flu-like symptoms), FEELING HOT (Was hot) and PYREXIA (I think I had a fever) had resolved.            On an unknown date the patient received first dose of Moderna vaccine, full dose with unknown lot number. On an unknown date the patient received second dose of Moderna vaccine, full dose with unknown lot number. On an unknown date the patient received first booster of Moderna vaccine, booster dose with unknown lot number. On an unknown date the patient received second booster of Moderna vaccine, booster dose with unknown lot number. Patient reported no side effects from the previously administered four doses of Moderna vaccines.
The following day, I had a killer headache (expected) and tinnitus was ROARING in my head. Normally, I have a lower level of tinnitus in my right ear, and now, for three days, I have had extremely loud tinnitus that I can actually hear over the wind blowing and music and people talking. My head hurts and I hate it.
redness in my arm; Swelling around the shot; headache; a low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness in my arm), INJECTION SITE SWELLING (Swelling around the shot), HEADACHE (headache) and PYREXIA (a low grade fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced ERYTHEMA (redness in my arm), INJECTION SITE SWELLING (Swelling around the shot), HEADACHE (headache) and PYREXIA (a low grade fever). On 06-Feb-2021, HEADACHE (headache) and PYREXIA (a low grade fever) had resolved. On 08-Feb-2021, INJECTION SITE SWELLING (Swelling around the shot) had resolved. At the time of the report, ERYTHEMA (redness in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided.  No treatment details were provided.
not being able to work/I can't work; not being able to walk; diagnosed with foot drop of the left foot, neurological symptom/ Patient can't lift her foot to walk, which makes her fall; This spontaneous case was reported by a nurse and describes the occurrence of IMPAIRED WORK ABILITY (not being able to work/I can't work), GAIT INABILITY (not being able to walk) and PERONEAL NERVE PALSY (diagnosed with foot drop of the left foot, neurological symptom/ Patient can't lift her foot to walk, which makes her fall) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031l20a and 032l20a) for COVID-19 vaccination.     The patient had never been diagnosed with/ tested positive for COVID-19.  The patient had no acute and chronic illness at the time of vaccination.  Patient did not received any other vaccine within 1 month prior to Moderna COVID-19 vaccine.  The patient to seek medical care like office visit due to adverse events and patient did not had insurance when patient received the vaccine.  The patient had not experienced similar adverse event in the past.  Concurrent medical conditions included Latex allergy, Sulfonamide allergy (Sulfa drugs), Asthma and Blood pressure. Concomitant products included LISINOPRIL and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced PERONEAL NERVE PALSY (diagnosed with foot drop of the left foot, neurological symptom/ Patient can't lift her foot to walk, which makes her fall). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (not being able to work/I can't work) and GAIT INABILITY (not being able to walk). The patient was treated with Physical therapy for Gait inability and Physical therapy for Peroneal nerve palsy. At the time of the report, IMPAIRED WORK ABILITY (not being able to work/I can't work) and GAIT INABILITY (not being able to walk) outcome was unknown and PERONEAL NERVE PALSY (diagnosed with foot drop of the left foot, neurological symptom/ Patient can't lift her foot to walk, which makes her fall) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other concomitant medication included Asthma medication, Inhaler as needed, Blood Pressure medication. Patient was not happy. There is no treatment, there is physical therapy.   This case was linked to MOD-2021-034005 (Patient Link).
Tightening of throat, raspy throat,  facial and tongue swelling, rash on chest.
numbness in my arm and fingers; tingling like arm or leg fall asleep after receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in my arm and fingers) and PARAESTHESIA (tingling like arm or leg fall asleep after receiving the second dose) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 002B21A,) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DULOXETINE, CARBAMAZEPINE (TEGRETOL), BUPROPION, CLONAZEPAM (KLONOPIN) and ARIPIPRAZOLE (ABILIFY DISCMELT) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness in my arm and fingers) and PARAESTHESIA (tingling like arm or leg fall asleep after receiving the second dose). The patient was treated with BACLOFEN at a dose of 1 dosage form. At the time of the report, HYPOAESTHESIA (numbness in my arm and fingers) and PARAESTHESIA (tingling like arm or leg fall asleep after receiving the second dose) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
A ringing in both ears that sounds like white noise (Tinnitus).  I have not sought treatment but the ringing has not subsided.
Hx of fainting following vaccinations (6 and 10 y/o); non visualized fall resulting in abrasions on patient forehead, cheekbone, and jaw approximately 5-10 minutes post injection from sitting position on bench in front of pharmacy. Last episode 10+ years ago. Pharmacy tech called as patient was re-seated next to mom. RPh arrived mid conversation as patient began losing consciousness again with right arm muscle contraction lasting roughly 15 seconds. Following episode, he was able to answer questions ruling out mental alteration. Given treatment and education on care for his facial injuries and added 20 minutes to observation period.  Patient ambulated to car with mother stating she would drive. Plan in place for administration of the second dose.
Pt recv vax on 2/19/99; on 2/23/99 pt exp fever, chills, headache, congestion
Approximately 3 days after receiving the first dose of the Moderna Covid vaccine, I noticed a nodule in the lower bottom part of my neck, near my left collarbone.  This is the same side where I received the vaccine injection. The nurse I spoke to believes it might be a swollen supra clavicular lymph node.
Angioedema; Both legs were swollen from knee to ankles/ hands were swollen; rash on both legs; A spontaneous report was received from a consumer concerning a 74-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced hands, both legs were swollen from knee to ankles, rash on both legs, and angioedema.  The patient's medical history was not provided. Concomitant medications reported were atorvastatin, lisinopril, amlodipine and clonazepam.  On 20 Feb 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 031M20A) in the right arm for prophylaxis of COVID-19 infection.  On 22 Feb 2021, the patient experienced hands, both legs were swollen from knee to ankles, rash on both legs. The patient went to his doctor and the doctor thought it to be angioedema. Treatment details included antihistamine.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of events hands, both legs were swollen from knee to ankles, rash on both legs and angioedema were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 24-MAR-2023, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) injection (lot # W001518, expiration date: 13-JAN-2024 or lot # W007040, expiration date: 29-FEB-2024; no exact lot# and expiration date was provided) and varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # W008711, expiration date: 14-MAR-2024 or lot # W017552, expiration date: 01-JUN-2024; no exact lot# and expiration date was provided) (both strengths, doses, routes of administration and anatomical locations were not reported), both for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009079,2305USA009080,2305USA009081,2305USA009082, 2305USA009083, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009092, 2305USA009093, 2305USA009094, 2305USA009095.
stated by mom: rash appeared on thighs, arms, trunk 1 days p/vax;saw MD that day 27JAN98;rash may be d/t immun & don't get next shots w/o seeing immunologist;tx DPH;
vitiligo spread exponentially and still spreading; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Mar2021 as dose 1, single (Lot number: EN6206) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hashimotos" (unspecified if ongoing); "Vitiligo" (unspecified if ongoing); "sjogrens possible RA" (unspecified if ongoing); "Possible RA" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: CYMBALTA; RAMIPRIL; AMBIEN; LEVOXYL; LEVOTHYROXINE. The following information was reported: VITILIGO (non-serious), outcome "not recovered", described as "vitiligo spread exponentially and still spreading".  Additional Information: The patient did not receive other vaccines within four weeks prior to COVID vaccine. The patient had no known allergies. Since the vaccination, the patient had not been tested for COVID-19.
Patient became lightheaded immediately after vaccine was given, even thought patient was given juice prior to vaccine administration.  Became very pale and nauseated, although did not vomit.  Patient continued to lay in supine position with legs elevated for 20 minutes. After 20 minutes, patient sat up for another 5 minutes and then left the office without another incident.
Uncontrollable screaming, crying shortly after vaccination was given. This carried on for 8 hours. Patient would not eat or nurse for almost 8 hours because he was screaming and clearing in pain. At the time he was eating every 2 hours. We gave him infant Tylenol (proper dosage for his size and age) after the screaming and crying would not stop 5 hours after vaccinations. My son was never colicky or a cryer. I believe it was encephalitis brought on by the Dtap vaccine.
This spontaneous report was received from a physician concerning a 62 year old patient (gender unknown). The patient's concurrent conditions and medical history were not reported. On an unspecified date in October 2014, reported as 1 year ago, the patient was vaccinated with a dose of ZOSTAVAX (dose, lot#, expiration date, route and anatomical location were not reported). Co-suspect therapies or concomitant medications were not provided. The physician reported that during a meeting, the patient, developed redness, swelling, and warmth at the injection site after administration of ZOSTAVAX, 1 year ago, an unspecified date, in October 2014. The patient was treated with ibuprofen (manufacturer unknown). The outcome of injection site erythema, injection site warmth and injection site swelling was reported as recovered in 1 week, on an unspecified date approximately in October, 2014. The relatedness between the events and suspect therapy was not provided. Additional information has been requested.
Once I got vaccinated i got fevers, chills, body ache, head ache, chest pains, constipation, lack of appetite, rash in my upper body and face. wickness. All these symptons lasted me a whole week after vaccination. also lower back pains which i suspect were my kidneys.
Redness and swelling on RVL day after shot. Redness and swelling spread day 2 no treatment needed
LEFT ARM PAIN.  THEN LEFT NECK PAIN, HARD TO MOVE HEAD. HEADACHE. CHILLS. CHATTERING TEETH.  SHAKING ARMS. FEVER. SEVERE LEG PAIN.  HAD TO HOLD ONTO FURNITURE TO WALK.  LEGS HURT JUST LAYING IN BED.
Received imms. 6/9/09. On 6/10/09 was achy and 102 degrees fever. On 6/13/09 pt again at clinic c/o nausea, abd cramping, and fever.
Approximately 6 to 8 hours after the injection, the injection site and upper arm got raised and swollen, red  and hot to the touch   Patient said arm hurt at injection site
left arm pain starting a few hours after administration, continuing now for 3 months. No improvement, gradual worsening.
A week after receiving the shot, I started experiencing severe pain in my left calf. On Friday, April 9, I was diagnosed with 2 blood clots in my left leg (Thrombus in the posterior tibial vein on the left.).
Information was received on 09FEB2018 from a review of scientific literature. This is a case of a 25 year-old female who underwent smallpox vaccination and experienced auto transfer of smallpox vaccinia virus to both labia minora. The patient denied history sexually transmitted infections. In 2014, the female received her first smallpox vaccination percutaneously. She subsequently developed the typical blister-like lesion at the vaccine site (left deltoid). On day-10, during the course of a  bandage change, she wiped the lesion with a paper toweland reportedly inadvertently wiped her labia minor and majora with the same paper towel. She presented approximately 1 week later (day-17) with 1-2 cm non-painful, non-tender lesions on both labia minora. The lesions had the same vesicular appearance as the original immunization site and upon evaluation by culture had the same strain of vaccinia virus as the original immunization solution. In 20 days, the lesions completely resolved without sequelea; Sender's Comments: This case is considered medically significant; as a requirement under 21 CFR 600.90(c)(d2) as stated in the approval letter (31AUG2007), 15-day submission is required for cases of autoinoculation. There is a positive temporal association. Autoinoculation is a known effect of immunization with smallpox vaccine and therefore these events are considered related to ACAM2000.
Patient complains of multiple syptoms following second dose of Pfizer and have persisted now greater than 18 months. C/O chronic palpitations, chest tightness, elevated blood pressures with abnormal ekg, feels flushed, ongoing vertigo and muscle weakness, excessive bleeding and enlarged blood vessels in legs.
Within 5 minutes dizziness, right arm numb extend to digits, cold arm, then progressed to left arm, As walked to car perioral numbness and on tongue, Went to urgent care - Dizzy, head under water feel, Speech not making sense, lateral neck pain, sense of increased heart rate, tongue felt swollen, O2 100%, Treated with benadryl and felt better within 15 min., Legs tingly the next day with some dizziness and arm symptoms resolved after 2 days.
invalid dosing interval outside 37 days; muscle ache; headache, fatigue and body ache are impacting acitivites of daily living; Fever; chills; Headache; fatigue; Swelling; redness right arm; body ache; over sleeping; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING (Swelling), ERYTHEMA (redness right arm), PAIN (body ache), HYPERSOMNIA (over sleeping) and INTENTIONAL PRODUCT USE ISSUE (invalid dosing interval outside 37 days) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic headaches.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SWELLING (Swelling), ERYTHEMA (redness right arm), PAIN (body ache), HYPERSOMNIA (over sleeping), MYALGIA (muscle ache), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (headache, fatigue and body ache are impacting acitivites of daily living), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and FATIGUE (fatigue). On 15-Apr-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (invalid dosing interval outside 37 days). On 15-Apr-2021, SWELLING (Swelling), ERYTHEMA (redness right arm), HYPERSOMNIA (over sleeping), INTENTIONAL PRODUCT USE ISSUE (invalid dosing interval outside 37 days), MYALGIA (muscle ache), PYREXIA (Fever) and CHILLS (chills) had resolved. At the time of the report, PAIN (body ache), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (headache, fatigue and body ache are impacting acitivites of daily living), HEADACHE (Headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment information was reported.  Patient race was reported.